Recruiting

Cataract Surgery

Sponsor:

Aloha Vision Consultants

Code:

NCT07176416

Conditions

Cataract

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Veritas Vision System

Study Details

Brief summary:

This study is a single center, prospective study of cumulative dissipated energy and endothelial cells loss per phacoemulsification procedure after successful cataract surgery. Subjects will be assessed 3 months postoperatively at a single visit. Clinical evaluations will include central corneal thickness, specular microscopy, as well as measurement of visual acuities at distance.

Conditions

Cataract

Study ID

NCT07176416

Start date

Oct 3, 2025

Status verified date

Oct, 2025

Completion date

Oct 1, 2026

Anticipated

Primary completion date

Oct 1, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Adult patients undergoing age-related cataract surgery.
  • Planned use of the Catalys Precision Laser System.
  • Planned implantation of TECNIS intraocular lenses (IOLs).

Exclusion Criteria:

• Moderate-severe any disease state (deemed by the surgeon) that could increase risk of complicated cataract surgery (ie, pseudoexfoliation syndrome, zonular dehiscence, history of eye trauma, and prior refractive surgery).

Study Design

Enrollment

50 participants

Anticipated

Interventions and Outcome Measures

Interventions

Veritas Vision System

Veritas Vision System

Primary outcome measure

  • Effective phaco time per phacoemulsification procedure [ Time Frame: Surgery (Day 0) ]

Central Contacts and Locations

Central contacts

Alana K Dunn

808-688-6898avc.alanad@gmail.com

Locations

Aloha Vision Consultants

Recruiting

‘Aiea, Hawaii, United States, 96701

Contacts

Alana K Dunn

808-688-6898avc.alanad@gmail.com

Principal Investigator:

Carlton Yuen, MD

More Information

Sponsor

Aloha Vision Consultants

Last update posted

Oct 9, 2025

Last verified

Oct, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Aloha Vision Consultants on 2025-10-09.